By Mariam Sunny and Christy Santhosh May 5 (Reuters) - Pfizer said on Tuesday that it expects to return to stronger growth ...
Pfizer Inc. PFE will release earnings for its third quarter before the opening bell on Tuesday, May 5. Analysts expect the ...
Q1 2026 earnings call recap: revenue/EPS beat, 2026 guidance intact, Vyndamax & Comirnaty legal wins boost 2029+ outlook—read now.
Hosted on MSN
Pfizer Q1 earnings set as dividend appeal grows
Pfizer will report first-quarter earnings before Tuesday’s market open, with analysts expecting revenue of roughly $13.8 ...
Pfizer Chief Executive Albert Bourla is battling impending expirations for some blockbuster-drug patents and the precipitous ...
PFE has been testing $26 since February but has breached another key level Pfizer Inc (NYSE:PFE) stock is down 1.1% to trade ...
Nearly three years after the FDA approved Pfizer's bispecific antibody Elrexfio as a late-line treatment for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results